help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pierce, G. F.
Right arrow Articles by Mustoe, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pierce, G. F.
Right arrow Articles by Mustoe, T. A.

American Journal of Pathology, Vol 138, 629-646, Copyright © 1991 by American Society for Investigative Pathology


REGULAR ARTICLES

Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds

GF Pierce, J Vande Berg, R Rudolph, J Tarpley and TA Mustoe
Department of Experimental Pathology, Amgen Inc., Thousand Oaks, California 91320.

Recombinant platelet-derived growth factor (PDGF) and transforming growth factor beta 1 (TGF-beta 1) influence the rate of extracellular matrix formed in treated incisional wounds. Because incisional healing processes are difficult to quantify, a full-thickness excisional wound model in the rabbit ear was developed to permit detailed analyses of growth-factor-mediated tissue repair. In the present studies, quantitative and qualitative differences in acute inflammatory cell influx, glycosaminoglycan (GAG) deposition, collagen formation, and myofibroblast generation in PDGF-BB (BB homodimer)- and TGF-beta 1- treated wounds were detected when analyzed histochemically and ultrastructurally. Although both growth factors significantly augmented extracellular matrix formation and healing in 10-day wounds compared with controls (P less than 0.002). PDGF-BB markedly increased macrophage influx and GAG deposition, whereas TGF-beta 1 selectively induced significantly more mature collagen bundles at the leading edge of new granulation tissue (P = 0.007). Transforming growth factor-beta 1-treated wound fibroblasts demonstrated active collagen fibrillogenesis and accretion of subfibrils at the ultrastructural level. Myofibroblasts, phenotypically modified fibroblasts considered responsible for wound contraction, were observed in control, but were absent in early growth-factor-treated granulating wounds. These results provide important insights into the mechanisms of soft tissue repair and indicate that 1) PDGF-BB induces an inflammatory response and provisional matrix synthesis within wounds that is qualitatively similar but quantitatively increased compared with normal wounds; 2) TGF-beta 1 preferentially triggers synthesis and more rapid maturation of collagen within early wounds; and 3) both growth factors inhibit the differentiation of fibroblasts into myofibroblasts, perhaps because wound contraction is not required, due to increased extracellular matrix synthesis.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
L. B. Nanney, C. D. Woodrell, M. R. Greives, N. L. Cardwell, A. C. Pollins, T. A. Bancroft, A. Chesser, M. Michalak, M. Rahman, J. W. Siebert, et al.
Calreticulin Enhances Porcine Wound Repair by Diverse Biological Effects
Am. J. Pathol., September 1, 2008; 173(3): 610 - 630.
[Abstract] [Full Text] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
D. Prabu, M. Nappinnai, K. Ponnudurai, and K. Prabhu
Evaluation of Wound-Healing Potential of Pisonia grandis R.Br: A Preclinical Study in Wistar Rats
International Journal of Lower Extremity Wounds, March 1, 2008; 7(1): 21 - 27.
[Abstract] [PDF]


Home page
INT J LOW EXTREM WOUNDSHome page
J. Kopp, U. Kneser, A. D. Bach, and R. E. Horch
Buried Chip Skin Grafting in Neuropathic Diabetic Foot Ulcers Following Vacuum-Assisted Wound Bed Preparation: Enhancing a Classic Surgical Tool with Novel Technologies
International Journal of Lower Extremity Wounds, September 1, 2004; 3(3): 168 - 171.
[Abstract] [PDF]


Home page
Am J Sports MedHome page
A. Weiler, C. Forster, P. Hunt, R. Falk, T. Jung, F. N. Unterhauser, V. Bergmann, G. Schmidmaier, and N. P. Haas
The Influence of Locally Applied Platelet-Derived Growth Factor-BB on Free Tendon Graft Remodeling After Anterior Cruciate Ligament Reconstruction
Am. J. Sports Med., June 1, 2004; 32(4): 881 - 891.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Fraser, N. Brunskill, T. Ito, and A. Phillips
Long-Term Exposure of Proximal Tubular Epithelial Cells to Glucose Induces Transforming Growth Factor-{beta}1 Synthesis via an Autocrine PDGF Loop
Am. J. Pathol., December 1, 2003; 163(6): 2565 - 2574.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
D. Fraser, L. Wakefield, and A. Phillips
Independent Regulation of Transforming Growth Factor-{beta}1 Transcription and Translation by Glucose and Platelet-Derived Growth Factor
Am. J. Pathol., September 1, 2002; 161(3): 1039 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
J. Yamate, K. Sato, M. Ide, M. Nakanishi, M. Kuwamura, S. Sakuma, and S. Nakatsuji
Participation of Different Macrophage Populations and Myofibroblastic Cells in Chronically Developed Renal Interstitial Fibrosis after Cisplatin-induced Renal Injury in Rats
Vet. Pathol., May 1, 2002; 39(3): 322 - 333.
[Abstract] [Full Text] [PDF]


Home page
Arch Facial Plast SurgHome page
D. M. Powell, E. Chang, and E. H. Farrior
Recovery From Deep-Plane Rhytidectomy Following Unilateral Wound Treatment With Autologous Platelet Gel: A Pilot Study
Arch Facial Plast Surg, October 1, 2001; 3(4): 245 - 250.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
J. Yamate, M. Maeda, S. J. Benn, J. E. Laithwaite, A. Allan, M. Ide, M. Kuwamura, T. Kotani, S. Sakuma, and J. Lamarre
Differential Effects of Transforming Growth Factor-{beta}1, a Fibrogenic Factor, on Macrophage-Like Cells (HS-P) and Myofibroblastic Cells (MT-9) In Vitro
Toxicol Pathol, June 1, 2001; 29(4): 483 - 491.
[Abstract] [PDF]


Home page
Physiol. Rev.Home page
C.-H. Heldin and B. Westermark
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Physiol Rev, October 1, 1999; 79(4): 1283 - 1316.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
E. A. Chen, L. Zhao, M. Bamat, R. von Borstel, and T. Mustoe
Acceleration of Wound Healing With Topically Applied Deoxyribonucleosides
Arch Surg, May 1, 1999; 134(5): 520 - 525.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
C. J. Corral, A. Siddiqui, L. Wu, C. L. Farrell, D. Lyons, and T. A. Mustoe
Vascular Endothelial Growth Factor Is More Important Than Basic Fibroblastic Growth Factor During Ischemic Wound Healing
Arch Surg, February 1, 1999; 134(2): 200 - 205.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Liu, D. Fitzli, M. Liu, I. Tseu, I. Caniggia, D. Rotin, and M. Post
PDGF-induced glycosaminoglycan synthesis is mediated via phosphatidylinositol 3-kinase
Am J Physiol Lung Cell Mol Physiol, May 1, 1998; 274(5): L702 - L713.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society for Investigative Pathology.